Thompson Davis & Co., Inc. Editas Medicine, Inc. Transaction History

Thompson Davis & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$26.55 - $40.57 $16,593 - $25,356	-625 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$27.65 - $38.39 $38,018 - $52,786	-1,375 Reduced 68.75%	625 $20,000
Q2 2018 Aug 03, 2018	BUY	$31.4 - $41.01 $19,625 - $25,631	625 Added 45.45%	2,000 $72,000
Q1 2018 May 02, 2018	BUY	$29.84 - $44.08 $41,030 - $60,610	1,375 New	1,375 $46,000

240

56.5M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $85.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.